Posts

A new approach to stop cancer growth?

CLEVELAND– Case Western Reserve University biochemical researchers have identifi...

Dectin-1 stimulation promotes distinct inflammatory sig...

“To our knowledge, our study is the first to evaluate the specific function of D...

Illuminating new horizons: Navigating nonlinear scatter...

In the intricate world of light, a journey through inhomogeneous media often lea...

Striking gold with molecular mystery solution for poten...

UNIVERSITY PARK, Pa. — Hydrogen spillover is exactly what it sounds like. Small ...

Housing heroes: New program to support veterans experie...

Since 2009, the number of veterans experiencing homelessness across the United S...

Heart transplant patients from socioeconomically distre...

FINDINGS Credit: Wikimedia Commons FINDINGS People from socioeconomically distre...

How little things can reduce hip fractures

Simple strategies to strengthen your bones, implemented by the whole community n...

Novocure’s TTFields Misses the Mark in Phase 3 Ovarian ...

In a striking departure from earlier this year’s promising findings, Novocure’s ...

GE HealthCare introduces Vscan Air SL: a handheld ultra...

GE Healthcare has unveiled its latest innovation: the Vscan Air SL handheld ultr...

BridgeBio Explores Phase 3 Acoramidis Data in Depth

BridgeBio is delving deeper into the phase 3 research of acoramidis, focusing on...

Boston Scientific’s Farapulse System Irregular Heartbea...

Boston Scientific, a pioneering force in medical technology, has revealed clinic...

Self-adjusting spinal cord stimulator from Medtronic re...

While traditional systems for spinal cord stimulation play a significant role in...

Alvotech and Bioventure gain approval for Humira biosim...

Alvotech and Bioventure received the Egyptian Drug Authority's approval to produ...

Ipilimumab by Bristol-Myers Squibb for Metastatic Trans...

Ipilimumab is under clinical development by Bristol-Myers Squibb and currently i...

FDA shuns Outlook Therapeutics with wet AMD drug BLA re...

Shares in the company tanked 80% following the FDA issued a CRL for its bevacizu...

Codagenix pursues RSV vaccine development amid unexpect...

Codagenix faces a late 2024 data readout following enrollment challenges in its ...